A patient comes to you complaining that whenever he takes aspirin for headache, he develops severe shortness of breath. Which of the following may be partly responsible for this effect ?
**Core Concept**
Aspirin is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes, leading to a reduction in prostaglandin synthesis. Prostaglandins play a crucial role in maintaining the balance between vasodilation and vasoconstriction, as well as regulating platelet aggregation. The blockade of COX enzymes can lead to an imbalance in these processes, resulting in various side effects, including respiratory symptoms.
**Why the Correct Answer is Right**
The correct answer is related to the inhibition of COX enzymes, specifically COX-1, which is involved in the production of prostaglandins that maintain the integrity of the gastric mucosa and regulate platelet aggregation. However, in this case, the correct answer is actually related to the inhibition of COX-1 in platelets, leading to an imbalance in platelet aggregation. The production of thromboxane A2 (TXA2) is inhibited, while the production of prostacyclin (PGI2) is not significantly affected in this patient. This imbalance can lead to an increase in platelet aggregation, which may be partly responsible for the patient's symptoms. The inhibition of COX-1 in platelets is more relevant to the patient's symptoms than the inhibition of COX-1 in the gastric mucosa.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not relate to the patient's symptoms. The inhibition of COX-1 in the gastric mucosa leads to a decrease in prostaglandin production, which can cause gastric mucosal damage and ulcers, not respiratory symptoms.
**Option B:** This option is incorrect because it does not explain the patient's symptoms. The inhibition of COX-2 is more relevant to the treatment of pain and inflammation, and not directly related to platelet aggregation or respiratory symptoms.
**Option C:** This option is incorrect because it does not explain the patient's symptoms. The inhibition of lipoxygenase is involved in the production of leukotrienes, which are involved in inflammation, but not directly related to platelet aggregation or respiratory symptoms.
**Option D:** This option is incorrect because it does not explain the patient's symptoms. The inhibition of phosphodiesterase is involved in the regulation of smooth muscle tone and platelet aggregation, but not directly related to the inhibition of COX enzymes.
**Clinical Pearl / High-Yield Fact**
The patient's symptoms are likely due to an imbalance in platelet aggregation, which can be partly responsible for the development of respiratory symptoms. This is a classic example of how the inhibition of COX enzymes can lead to an imbalance in platelet aggregation, and highlights the importance of considering the specific COX enzyme isoform involved in the patient's symptoms.
**Correct Answer: C. Inhibition of COX-1 in platelets, leading to an imbalance in platelet aggregation.**